Kathleen Tregoning
Director/Board Member bij SPERO THERAPEUTICS, INC.
Vermogen: 450 852 $ op 31-03-2024
Profiel
Kathleen Tregoning is currently an Independent Director at Spero Therapeutics, Inc. since 2021 and the Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc. since 2020.
Previously, she served as the Executive Vice President-External Affairs at Sanofi from 2017 to 2020.
She also held the position of Senior Vice President-Corporate Affairs at Biogen France SAS.
Ms. Tregoning completed her undergraduate degree at Stanford University and her graduate degree at Harvard Kennedy School of Government.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 19-01-2024 | 10 666 ( 0.01% ) | 450 852 $ | 31-03-2024 | |
SPERO THERAPEUTICS, INC.
-.--% | 08-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Kathleen Tregoning
| Bedrijven | Functie | Begin |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Public Communications Contact | 01-07-2020 |
| SPERO THERAPEUTICS, INC. | Director/Board Member | 11-10-2021 |
Eerdere bekende functies van Kathleen Tregoning
| Bedrijven | Functie | Einde |
|---|---|---|
| SANOFI | Public Communications Contact | 01-03-2020 |
Biogen France SAS
 Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Opleiding van Kathleen Tregoning
| Stanford University | Undergraduate Degree |
| Harvard Kennedy School of Government | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SANOFI | Health Technology |
| SPERO THERAPEUTICS, INC. | Health Technology |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Health Technology |
